ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP04

MCTD and Aging – Resilience Required

Carol Kaminski

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, lupus-like disease, Miscellaneous Rheumatic and Inflammatory Diseases, Raynaud's, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (PP01-PP08) Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: I was diagnosed with MCTD at age 25. My priorities were understanding a disease I had trouble pronouncing, and trying to learn to live with it, not die from it.  I did not think I would live to an old age.  40 years on, here are my strategies on aging well with MCTD that may help rheumatic disease patients and professionals who treat them, to either avoid my errors or employ helpful behaviors. I’ve learned these through trial and error and also observed them in others “chronically managing.”

Intervention: Since I did not believe I would definitely reach old age my lifestyle reflected that. I was told, “Some patients do very well; others live only a few years.”  That conversation couldn’t be unheard. Why plan for an uncertain future?

As each year brought improvements in the care of autoimmune diseases, and the chance I would have a future, my hope increased. One pivotal period for me was when histamine-2 blockers and proton-pump inhibiters were developed.  I feel such gratitude for those involved in the development of gastrointestinal motility and acid-suppressing drugs. My quality of life improved overnight. Any medical improvement may be “right around the corner” so why not plan for that? I began to contribute to a retirement account at work.  Once I felt I might have a future, I began to plan for one.

A doctor said to me “some things take a “tincture of time” to resolve.  Along with managing MCTD, I am subject to everyday problems and unrelated diseases.  I appreciated this concept while waiting for hydroxychloroquine to kick in; By simply resting joints or muscles before deciding I am flaring gave me time for clarity.  Although not appropriate for all situations, there are times to wait.

When in pain, I move slower, and my focus lessens. I mitigate by managing my calendar better, so I am not overbooked or hurried.  I leave earlier for appointments.  With joints damaged from years of swelling and arthritis, when I rush, I drop or forget things.  Others’ time is valuable too, so I strive to be on time. I cancel plans when rest is required, something not always understood by others.

Early in my chronic illness journey I found myself relying on and at times being disappointed by friends and family.  Experiencing a lack of understanding and even denial at diagnosis, I learned the reality no one person can always be there for me.  Sometimes, I’d call only to find others caught up in their own situations, not tuned into me.  This is normal. How happy it makes me when I get help, a listening ear, or a sense of understanding.  But maturity allows me to let it go when I don’t. Adding frustration and disappointment to things doesn’t help. The process also developed my resilience and allows me to empathize with others.

Alongside the emotional work of understanding, forgiving, or choosing to move on, I began to simply increase my support system. Online and in-person support groups.  Viewing close friends/partner as adjunct support, rather than primary. These actions release those closest to me from the pressure of being “always on.”

Maintenance: Today, I prioritize activities and investments that promote health, physical, mental, emotional and spiritual.

Quality of Life: By doing so, I am able to live a better, fuller and perhaps even a healthier life.

Takeaway: May more of us live healthier years with, even in spite of chronic illness, even into older age.


Disclosures: C. Kaminski: None

To cite this abstract in AMA style:

Kaminski C. MCTD and Aging – Resilience Required [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/mctd-and-aging-resilience-required/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mctd-and-aging-resilience-required/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology